<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="reply">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id>
      <journal-id journal-id-type="publisher-id">acn3</journal-id>
      <journal-title-group>
        <journal-title>Annals of Clinical and Translational Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2328-9503</issn>
      <issn pub-type="epub">2328-9503</issn>
      <publisher>
        <publisher-name>John Wiley &amp; Sons, Ltd</publisher-name>
        <publisher-loc>Chichester, UK</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26290895</article-id>
      <article-id pub-id-type="pmc">4531063</article-id>
      <article-id pub-id-type="doi">10.1002/acn3.217</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Reply to Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Reply to comment on: A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dominov</surname>
            <given-names>Janice A</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Uyan</surname>
            <given-names>Özgün</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sapp</surname>
            <given-names>Peter C</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McKenna-Yasek</surname>
            <given-names>Diane</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nallamilli</surname>
            <given-names>Babi Ramesh Reddy</given-names>
          </name>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hegde</surname>
            <given-names>Madhuri</given-names>
          </name>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>Robert H</given-names>
            <suffix>Jr</suffix>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <aff id="au1">
          <label>1</label>
          <institution>Neurology Department, University of Massachusetts Medical School</institution>
          <addr-line>Worcester, Massachusetts</addr-line>
        </aff>
        <aff id="au2">
          <label>2</label>
          <institution>Department of Human Genetics, Emory University School of Medicine</institution>
          <addr-line>Atlanta, Georgia</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence</bold> Tel: 508-334-1271; Fax: 508-856-4485; E-mail: <email>Robert.Brown@umassmed.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <volume>2</volume>
      <issue>7</issue>
      <fpage>785</fpage>
      <lpage>785</lpage>
      <permissions>
        <copyright-statement>© 2015 The Authors. <italic>Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals, Inc on behalf of American Neurological Association.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p>
        </license>
      </permissions>
      <related-article related-article-type="letter" id="d35e139" vol="2" page="783" xlink:href="26273692" ext-link-type="pubmed"/>
    </article-meta>
  </front>
  <body>
    <p>We were delighted to read the comments from our colleague, Dr. Martin Krahn and his team,<xref rid="b1" ref-type="bibr">1</xref> noting that they, too, detect the deep intronic dysferlin mutation that we described.<xref rid="b2" ref-type="bibr">2</xref> We fully agree that this will likely be an infrequent mutation, even in the population of dysferlinopathy cases with only one known exonic dysferlin mutation, though it might be recurrent in specific populations. We anticipate that there will be other mutations deep within introns and other regulatory regions that will be identified through expanded strategies to screen for mutations such as the RNA analyses described in our paper, which could be applied to screens for other diseases as well.</p>
    <sec>
      <title>Conflict of Interest</title>
      <p>J. A. D. and R. H. B. Jr. are employed by the University of Massachusetts Medical School and co-inventors on a pending patent application: “COMPOSITIONS AND METHODS FOR MODULATING DYSFERLIN EXPRESSION”. Dr. Brown reports grants from Cecil B. Day Foundation, grants from NIH-NINDS, and other from Howard Hughes Medical Institute.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kergourlay</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Blandin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Blanck</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comment on: a novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides</article-title>
          <source>Ann Clin Transl Neurol</source>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="b2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dominov</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides</article-title>
          <source>Ann Clin Transl Neurol</source>
          <year>2014</year>
          <volume>1</volume>
          <fpage>703</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="pmid">25493284</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

